More SEC Filings
View Older Stories View Newer Stories-
Form 424B5 Solowin Holdings, Ltd.
-
Form 485BXT NATIONWIDE MUTUAL FUNDS
-
Form SCHEDULE 13G/A Nexxen International Filed by: JB CAPITAL PARTNERS LP
-
Form SCHEDULE 13G/A Nexxen International Filed by: JB CAPITAL PARTNERS LP
-
Form 424B2 CITIGROUP INC
-
Form 497 Cohen & Steers Future
-
Form N-23C3A Columbia Credit Income For: Feb 09
-
Form 6-K PEARSON PLC For: Feb 09
-
Form 13F-HR Frazier Financial Adviso For: Dec 31
-
Form 25-NSE V F CORP Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 13F-HR Powell Investment Adviso For: Dec 31
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 25-NSE Lemonade, Inc. Filed by: NYSE AMERICAN LLC
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form D/A 275 Funding, LLC
-
Form ABS-15G Zolve Financials LLC For: Dec 31
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form FWP National Bank Holdings Filed by: National Bank Holdings Corp
-
Form 6-K ParaZero Technologies For: Feb 09
-
Form 8-K SM Energy Co For: Feb 04
-
Form F-1/A Horizon Thread (PTY)
-
Form 497J FT 12718
-
Form 497J FT 12782
-
Form 497J FT 12742
-
Form SCHEDULE 13D/A Commercial Vehicle Group Filed by: Lakeview Opportunity Fund LLC
-
Form 8-K FB Bancorp, Inc. /MD/ For: Feb 09
-
Form 8-K Valaris Ltd For: Feb 09
-
Form SCHEDULE 13G/A Ryerson Holding Corp Filed by: JB CAPITAL PARTNERS LP
-
Form 6-K Diginex Ltd For: Jan 30
-
Form 6-K Energys Group Ltd For: Feb 09
-
Form 6-K ASCENTAGE PHARMA GROUP For: Feb 09
-
Form 8-K TriSalus Life Sciences, For: Feb 03
-
Form 497J FT 12741
-
Form 13F-HR Catalyst Funds Managemen For: Dec 31
-
Form 8-K SYNCHRONOSS TECHNOLOGIES For: Feb 09
-
Form 497J FT 12739
-
Form 424B5 National Bank Holdings
-
Form 13F-HR Fox Financial, Inc For: Dec 31
-
Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR Darden Wealth Group Inc For: Dec 31
-
Form 8-K Limitless X Holdings For: Jan 26
-
Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR OLD REPUBLIC INTERNATION For: Dec 31
-
Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A LIFETIME BRANDS, INC Filed by: JB CAPITAL PARTNERS LP
-
Form 8-K Nukkleus Inc. For: Feb 09
-
Form 8-K AVANT TECHNOLOGIES INC. For: Feb 03
-
Form TA-2 NORTHEAST INVESTORS TRUS For: Dec 31
-
Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form 3 Entera Bio Ltd. For: Feb 04 Filed by: Germano Geno J


